Literature DB >> 8519049

Formularies: the role of pharmacy-and-therapeutics (P&T) committees.

K H Summers1, S L Szeinbach.   

Abstract

Pharmacy-and-therapeutics (P&T) committees have been established by most hospitals and serve as the primary formal communications link between pharmacy and the medical staff. The P&T committee is responsible for all matters related to the use of medications in the institution, including the development and maintenance of the formulary (the continually revised compilation of drug products available to the medical staff). The basic objectives of a P&T committee are to specify drugs of choice and alternatives, based on safety and efficacy; to minimize therapeutic redundancies; and to maximize cost-effectiveness. Procedures necessary to strengthen the role of P&T committees and improve their decision-making processes are discussed. The increasing concern with controlling health care costs will support the continued expansion of P&T committees, formularies, and the formulary system.

Entities:  

Mesh:

Year:  1993        PMID: 8519049

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  8 in total

1.  Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.

Authors:  R Fijn; J R Brouwers; R J Knaap; L T De Jong-Van Den Berg
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Prioritising drug and therapeutics committee (DTC) decisions: a national survey.

Authors:  Ee Lyn Tan; Richard O Day; Jo-anne E Brien
Journal:  Pharm World Sci       Date:  2006-12-23

3.  Rule-based standardised switching of drugs at the interface between primary and tertiary care.

Authors:  Stefanie U Walk; Thilo Bertsche; Jens Kaltschmidt; Markus G Pruszydlo; Torsten Hoppe-Tichy; Ingeborg Walter-Sack I; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2007-11-25       Impact factor: 2.953

4.  Indicators for drug and therapeutics committees.

Authors:  L M Weekes; C Brooks; R O Day
Journal:  Br J Clin Pharmacol       Date:  1998-04       Impact factor: 4.335

5.  [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].

Authors:  S Harder; P Thürmann; A Steioff
Journal:  Med Klin (Munich)       Date:  1998-02-15

Review 6.  Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.

Authors:  B H Guze
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 7.  The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.

Authors:  L M Weekes; R O Day
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

8.  Feasibility of de-linking reimbursement of antimicrobials from sales: the Australian perspective as a qualitative case study.

Authors:  Nadine T Hillock; Tracy L Merlin; Jonathan Karnon; John Turnidge; Jaklin Eliott
Journal:  JAC Antimicrob Resist       Date:  2020-05-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.